GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allergan PLC (FRA:A60) » Definitions » Shares Outstanding (EOP)

Allergan (FRA:A60) Shares Outstanding (EOP) : 332 Mil (As of Mar. 2020)


View and export this data going back to 2015. Start your Free Trial

What is Allergan Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Allergan's shares outstanding for the quarter that ended in Mar. 2020 was 332 Mil.

Allergan's quarterly shares outstanding increased from Dec. 2019 (328 Mil) to Mar. 2020 (332 Mil). It means Allergan issued new shares from Dec. 2019 to Mar. 2020 .

Allergan's annual shares outstanding declined from Dec. 2018 (333 Mil) to Dec. 2019 (329 Mil). It means Allergan bought back shares from Dec. 2018 to Dec. 2019 .


Allergan Shares Outstanding (EOP) Historical Data

The historical data trend for Allergan's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergan Shares Outstanding (EOP) Chart

Allergan Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 394.50 334.90 330.20 332.60 329.00

Allergan Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 327.80 327.90 328.10 328.10 331.90

Competitive Comparison of Allergan's Shares Outstanding (EOP)

For the Drug Manufacturers - General subindustry, Allergan's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allergan's Shares Outstanding (EOP) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Allergan's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Allergan's Shares Outstanding (EOP) falls into.



Allergan Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Allergan  (FRA:A60) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Allergan Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Allergan's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Allergan (FRA:A60) Business Description

Traded in Other Exchanges
N/A
Address
Clonshaugh Business and Technology Park, Coolock, Dublin, IRL, D17E400
Allergan PLC is one of the largest specialty pharmaceutical manufacturers. It specializes in aesthetics, ophthalmology, women's health, gastrointestinal, and central nervous system products. The products offered by the company include Botox, Celexa, Fetzima, Refresh, Ozurdex and Zenpep among others.

Allergan (FRA:A60) Headlines

No Headlines